We are live on
!
Find out more
AI
ArchPoint Investors Portfolio holdings
AUM
$420M
1-Year Est. Return
42.19%
This Fund
S&P 500
This Quarter
Est. Return
+12.45%
1 Year Est. Return
+42.19%
3 Year Est. Return
+98.24%
5 Year Est. Return
+100.5%
10 Year Est. Return
+371.01%
AUM
$347M
AUM Growth
+$7.88M
(+2.3%)
Cap. Flow
-$19.3M
Cap. Flow
% of AUM
-5.56%
Top 10 Holdings %
Top 10 Hldgs %
67.41%
Holding
160
New
5
Increased
32
Reduced
31
Closed
22
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
+$3.77M |
| 2 |
GREK
Global X MSCI Greece ETF
GREK
|
+$3.6M |
| 3 |
Neurocrine Biosciences
NBIX
|
+$1.43M |
| 4 |
Amazon
AMZN
|
+$1.22M |
| 5 |
Merck
MRK
|
+$887K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RSX
VanEck Russia ETF
RSX
|
+$5.39M |
| 2 |
Northrop Grumman
NOC
|
+$4.23M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$3.56M |
| 4 |
Philip Morris
PM
|
+$3.04M |
| 5 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
+$3.01M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 42.12% |
| 2 | Consumer Discretionary | 11.91% |
| 3 | Healthcare | 9.88% |
| 4 | Energy | 7.17% |
| 5 | Real Estate | 4.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Alphabet (Google) Class A
GOOGL
$4.08T
| $85.5M | 24.63% |
1,514,440
| – | – |
|
|
2
Alphabet (Google) Class C
GOOG
$4.07T
| $52.6M | 15.16% |
943,100
| – | – |
|
|
3
Amazon
AMZN
$2.48T
| $17.7M | 5.1% |
208,340
+15,340
| +8% | +$1.22M |
|
4
La-Z-Boy
LZB
$1.65B
| $16.6M | 4.78% |
542,726
| – | – |
|
5
Regenxbio
RGNX
$615M
| $14.8M | 4.25% |
205,714
+3,290
| +2% | +$157K |
|
6
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.83B
| $14.2M | 4.1% |
450,800
| – | – |
|
7
Blackstone Mortgage Trust
BXMT
$2.81B
| $10.3M | 2.97% |
321,646
| – | – |
|
8
State Street SPDR S&P Biotech ETF
XBI
$10.1B
| $8.84M | 2.55% |
92,877
+2,660
| +3% | +$244K |
|
9
iShares Biotechnology ETF
IBB
$9.55B
| $7.16M | 2.06% |
65,073
| – | – |
|
10
VanEck Oil Services ETF
OIH
$1.99B
| $6.25M | 1.8% |
11,902
+70
| +0.6% | +$37.5K |
|
11
Dorchester Minerals
DMLP
$1.3B
| $5.53M | 1.59% |
268,523
+3,140
| +1% | +$58.2K |
|
|
KREF
12
KKR Real Estate Finance Trust
KREF
$471M
| $5.43M | 1.57% |
268,798
| – | – |
|
|
ATVI
13
DELISTED
Activision Blizzard
ATVI
| $5.05M | 1.45% |
66,146
+2,000
| +3% | +$142K |
|
14
Thermo Fisher Scientific
TMO
$214B
| $4.96M | 1.43% |
23,934
+750
| +3% | +$159K |
|
15
Curtiss-Wright
CW
$26.9B
| $4.81M | 1.38% |
40,339
+1,025
| +3% | +$134K |
|
16
Genuine Parts
GPC
$17.9B
| $4.43M | 1.28% |
47,940
| – | – |
|
|
17
Merck
MRK
$326B
| $4.07M | 1.17% |
69,709
+15,720
| +29% | +$887K |
|
|
GBT
18
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $4.02M | 1.16% |
88,840
+82,840
| +1,381% | +$3.77M |
|
19
Willis Towers Watson
WTW
$29.9B
| $3.81M | 1.1% |
25,033
| – | – |
|
20
State Street SPDR S&P 500 ETF Trust
SPY
$783B
| $3.42M | 0.98% |
12,532
-10,782
| -46% | -$2.91M |
|
|
RDS.B
21
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $3.41M | 0.98% |
46,983
-6,710
| -12% | -$483K |
|
|
GREK
22
Global X MSCI Greece ETF
GREK
$291M
| $3.36M | 0.97% |
+122,804
| New | +$3.6M |
|
23
Lockheed Martin
LMT
$134B
| $3.34M | 0.96% |
11,318
+245
| +2% | +$79K |
|
24
Boston Scientific
BSX
$68.5B
| $2.89M | 0.83% |
88,438
| – | – |
|
|
APC
25
DELISTED
Anadarko Petroleum
APC
| $2.56M | 0.74% |
34,963
| – | – |
|
Similar funds
HWMG
MG
CWM
IMA
CMHI
WCG
TFP
BRM
ArchPoint Investors's Q2 2018 Portfolio in Review
As of Q2 2018, ArchPoint Investors held 160 positions worth $347M, up 2.3% from $339M the previous quarter. Its ten largest holdings account for 67% of the portfolio.
ArchPoint Investors withdrew a net $19.3M in Q2 2018, closing 22 positions and reducing 31 holdings. Its most notable exit was Northrop Grumman, an estimated $4.23M position sold in full.
By sector, the portfolio is most concentrated in Communication Services at 42% of assets, up from 40% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, ArchPoint Investors opened a new position in Global X MSCI Greece ETF worth $3.36M.
- ArchPoint Investors's largest Q2 2018 buy was Global X MSCI Greece ETF: 122,804 shares worth $3.36M.
- ArchPoint Investors added most to Global Blood Therapeutics, Inc. in Q2 2018, an estimated $3.77M increase.
- ArchPoint Investors's biggest Q2 2018 reduction was VanEck Russia ETF, cutting an estimated $5.39M.
- ArchPoint Investors fully exited Northrop Grumman in Q2 2018, selling an estimated $4.23M.
- ArchPoint Investors's ten largest holdings make up 67% of its $347M portfolio in Q2 2018.
- ArchPoint Investors opened 5 new positions and closed 22 in Q2 2018.
- ArchPoint Investors's portfolio value rose 2.3% quarter-over-quarter to $347M.
Based on ArchPoint Investors's 13F filing for Q2 2018, filed 14 Aug 2018.